Cellyan Biotechnology Co Ltd(HKPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HKPD Cellyan Biotechnology Co Ltd

Pre-Mkt 01-28 06:21:21 EST

0.8490

+0.0200

+2.41%

High0.8610	Low0.8100	Vol18.71K
Open0.8281	D1 Closing0.8290	Amplitude6.15%
Mkt Cap9.34M	Tradable Cap2.90M	Total Shares11.00M
T/O15.58K	T/O Rate0.55%	Tradable Shares3.42M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"HKPD","market":"US","secType":"STK","nameCN":"Cellyan Biotechnology Co Ltd","latestPrice":0.849,"timestamp":1769547600000,"preClose":0.829,"halted":0,"volume":18714,"delay":0,"changeRate":0.024125452352231628,"floatShares":3415580,"shares":11000000,"eps":-0.00246,"marketStatus":"Pre-Mkt","change":0.02,"latestTime":"01-28 06:21:21 EST","open":0.8281,"high":0.861,"low":0.81,"amount":15578.592,"amplitude":0.06152,"askPrice":0.9878,"askSize":100,"bidPrice":0.8005,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-0.00246,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1769610600000},"marketStatusCode":1,"adr":0,"listingDate":1736917200000,"exchange":"NASDAQ","adjPreClose":0.849,"postHourTrading":{"tag":"盘后","latestPrice":0.849,"preClose":0.849,"latestTime":"16:26 EST","volume":1,"amount":0.8321,"timestamp":1769549202450,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.808072963428724},"requestUrl":"/m/hq/s/HKPD","defaultTab":"news","newsList":[{"id":"2604091977","title":"Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2604091977","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604091977?lang=en_us&edition=fundamental","pubTime":"2026-01-17 05:30","pubTimestamp":1768599000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nTUA1P8LMF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4131","HKPD"],"gpt_icon":0},{"id":"2583837975","title":"Hong Kong Pharma Digital Technology Holdings Announces Board Resignations and New Committee Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2583837975","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583837975?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:30","pubTimestamp":1762983049,"startTime":"0","endTime":"0","summary":"Hong Kong Pharma Digital Technology Holdings Ltd. has announced the resignation of independent directors Raina Zou and King Yin Lai, both citing personal reasons. To address the resulting vacancy, the board has appointed Yao Mike Zhou as a member of the audit committee and chairperson of the compensation committee, effective November 6, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hong Kong Pharma Digital Technology Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDLhrcVn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4131","HKPD"],"gpt_icon":0},{"id":"2577515308","title":"Eddid Financial Celebrates 10th Anniversary with Grand Luncheon","url":"https://stock-news.laohu8.com/highlight/detail?id=2577515308","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577515308?lang=en_us&edition=fundamental","pubTime":"2025-10-23 18:38","pubTimestamp":1761215880,"startTime":"0","endTime":"0","summary":"HONG KONG, Oct. 23, 2025 /PRNewswire/ -- Eddid Financial  marked its 10thanniversary today with acelebratory luncheon at the Hong Kong Football Club. The event brought together a distinguished gathering of industry leaders, regional financial elites, and long-standing partners to commemorate a decade of remarkable transformation and chart an ambitious course for the future of both traditional and digital finance.The 10th anniversary celebration, themed \"A Decade of Seeing Beyond\" underscores the Group's relentless pursuit of innovation and strategic expansion throughout its ten-year journey. From pioneering traditional financial services to establishing a comprehensive digital asset ecosystem, Eddid Financial has consistently positioned itself at the vanguard of the industry, delivering cross-industry, cross-border, and cross-blockchain capital market solutions to clients worldwide.Eddid Financial established its virtual asset team years ago, with market-making services at its core, em","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/eddid-financial-celebrates-10th-anniversary-with-grand-luncheon-302592707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4087","HKPD","ANPA","BK4131"],"gpt_icon":0},{"id":"2573595604","title":"Hong Kong Pharma Digital Technology Holdings - on October 6, Accepted Resignation of CEO Wong Lap Sun From Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2573595604","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573595604?lang=en_us&edition=fundamental","pubTime":"2025-10-07 18:09","pubTimestamp":1759831775,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nFWN3VN2WB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4131","HKPD"],"gpt_icon":0},{"id":"2566846995","title":"Hong Kong Pharma Digital Technology Holdings Ltd. Appoints Zhou Mike Yao as Independent Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2566846995","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566846995?lang=en_us&edition=fundamental","pubTime":"2025-09-11 20:31","pubTimestamp":1757593864,"startTime":"0","endTime":"0","summary":"Hong Kong Pharma Digital Technology Holdings Ltd. has appointed Mr. Zhou Mike Yao as an independent director, effective September 9, 2025. Mr. Zhou, aged 34, brings extensive experience in investment and corporate development, having served in various leadership roles, including regional director of Norwich Capital Limited and owner of MYZ Corporate Relations Ltd. He will also join the company's nomination committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hong Kong Pharma Digital Technology Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 11, 2025, and is so","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nNDL8XTKF7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4131","HKPD"],"gpt_icon":0},{"id":"2559964429","title":"Hong Kong Pharma Reports 33% Increase in Net Profit to $1.33M for Fiscal Year Ending March 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2559964429","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559964429?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:38","pubTimestamp":1755203898,"startTime":"0","endTime":"0","summary":"Hong Kong Pharma Digital Technology Holdings Ltd. has released its annual financial results for the fiscal year ending March 31, 2025. The company reported a net profit of $1.33 million, marking a significant increase of 33% from the previous year's net profit of $998,196. The gross profit for the year amounted to $3.56 million, up 30% from the prior period's $2.74 million. Cost of revenues rose by 34% to $13.13 million from $9.82 million in the previous year. Selling, general, and administrative expenses increased by 7% to $1.89 million compared to $1.76 million the year before. The company's profit before income taxes was $1.53 million, reflecting a 49% increase from the prior fiscal year's $1.02 million. Income tax expenses were reported at $196,252, up from $22,574. Hong Kong Pharma attributes its financial performance to factors such as maintaining a competitive value proposition, key customer relationships, and successful marketing and sales activities. The company continues to f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDL6r8zRz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4131","HKPD"],"gpt_icon":0},{"id":"2556562658","title":"Hong Kong Pharma Digital Tech Delays Annual Report Due to Financial Statement Delays","url":"https://stock-news.laohu8.com/highlight/detail?id=2556562658","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556562658?lang=en_us&edition=fundamental","pubTime":"2025-08-01 04:30","pubTimestamp":1753993851,"startTime":"0","endTime":"0","summary":"Hong Kong Pharma Digital Technology Holdings Ltd. has announced a delay in filing its Annual Report on Form 20-F for the financial year ended March 31, 2025. The delay is attributed to unanticipated issues in completing its financial statements, which could not be resolved without unreasonable effort or expense. The company expects to file the report within 15 calendar days following the original due date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hong Kong Pharma Digital Technology Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 31, 2025, and is solely responsible","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nNDL3MRCKf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4131","HKPD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.9zt.hk","stockEarnings":[{"period":"1week","weight":0.063},{"period":"1month","weight":0.0666},{"period":"3month","weight":-0.3711},{"period":"6month","weight":-0.2143},{"period":"1year","weight":-0.6403},{"period":"ytd","weight":0.0298}],"compareEarnings":[{"period":"1week","weight":0.0264},{"period":"1month","weight":0.0075},{"period":"3month","weight":0.0118},{"period":"6month","weight":0.1003},{"period":"1year","weight":0.1604},{"period":"ytd","weight":0.0199}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Cellyan Biotechnology Co Ltd","nameEN":"Cellyan Biotechnology Co Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cellyan Biotechnology Co Ltd(HKPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Cellyan Biotechnology Co Ltd(HKPD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Cellyan Biotechnology Co Ltd,HKPD,Cellyan Biotechnology Co Ltd股票,Cellyan Biotechnology Co Ltd股票老虎,Cellyan Biotechnology Co Ltd股票老虎国际,Cellyan Biotechnology Co Ltd行情,Cellyan Biotechnology Co Ltd股票行情,Cellyan Biotechnology Co Ltd股价,Cellyan Biotechnology Co Ltd股市,Cellyan Biotechnology Co Ltd股票价格,Cellyan Biotechnology Co Ltd股票交易,Cellyan Biotechnology Co Ltd股票购买,Cellyan Biotechnology Co Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cellyan Biotechnology Co Ltd(HKPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Cellyan Biotechnology Co Ltd(HKPD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}